Aurora Cannabis Files 6-K Report

Ticker: ACB · Form: 6-K · Filed: 2025-08-06T00:00:00.000Z

Sentiment: neutral

Topics: sec-filing, 6-k, regulatory-update

TL;DR

Aurora Cannabis filed its Q2 2025 6-K, incorporating it into existing filings.

AI Summary

Aurora Cannabis Inc. filed a Form 6-K on August 6, 2025, for the period ending June 30, 2025. The company is a foreign private issuer and is submitting its report under the 1934 Securities Exchange Act. This filing is incorporated by reference into their existing registration statements on Form F-10 and Form S-8.

Why It Matters

This filing provides updated information for investors and regulatory bodies regarding Aurora Cannabis's financial and operational status as of the end of the second quarter of 2025.

Risk Assessment

Risk Level: low — This is a routine filing of a Form 6-K, which typically contains periodic financial and operational updates without significant new disclosures.

Key Players & Entities

AURORA CANNABIS INC (company) — Filer
0001683541-25-000015 (filing_id) — Accession Number
20250630 (date) — Conformed Period of Report
20250806 (date) — Filed as of Date
333-284958 (filing_id) — Form F-10 Registration Statement File Number
333-282253 (filing_id) — Form S-8 Registration Statement File Number

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically providing information that the issuer makes public in its home country or distributes to its security holders.

What period does this Form 6-K cover?

This Form 6-K covers the period ending June 30, 2025.

When was this Form 6-K filed?

This Form 6-K was filed on August 6, 2025.

What other SEC filings is this Form 6-K incorporated into?

This Form 6-K is incorporated by reference into Aurora Cannabis Inc.'s Registration Statements on Form F-10 (File No. 333-284958) and on Form S-8 (File No. 333-282253).

Is Aurora Cannabis Inc. filing an annual report under Form 20-F or Form 40-F?

Aurora Cannabis Inc. indicates it files annual reports under Form 40-F.

From the Filing

0001683541-25-000015.txt : 20250806 0001683541-25-000015.hdr.sgml : 20250806 20250806070241 ACCESSION NUMBER: 0001683541-25-000015 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250806 DATE AS OF CHANGE: 20250806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 251187389 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 form6-k20250630q12026.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F   [ ] Form 40-F  [X] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)  [ ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)  [ ] This Form 6-K is hereby filed and incorporated by reference in the registrant’s Registration Statements on Form F-10 (File No. 333-284958) and on Form S-8 (File No. 333-282253). SUBMITTED HEREWITH Exhibits Description 99.1 Condensed Consolidated Interim Financial Statements for the three months ended June 30, 2025 and 2024 99.2 Interim Management’s Discussion and Analysis for the three months ended June 30, 2025 and 2024 99.3 Certification of Chief Executive Officer 99.4 Certification of Chief Financial Officer      SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Simona King              Simona King Chief Financial Officer Date: August 6, 2025      EX-99.1 2 fs20250630q12026.htm EX-99.1 Document AURORA CANNABIS INC. Interim Condensed Consolidated Financial Statements (Unaudited) For the three months ended June 30, 2025 and 2024 (in Canadian Dollars) AURORA CANNABIS INC. Interim Condensed Consolidated Statements of Financial Position (Unaudited) ($ thousands) Note June 30, 2025 March 31, 2025 $ $ Assets Current assets Cash and cash equivalents 140,160  137,921  Restricted cash 9, 2(c) 45,873  47,407  Accounts receivable 39,136  42,470  Biological assets 3 36,584  51,168  Inventory 4, 2(c) 191,679  187,925  Prepaids and other current assets 11,657  11,215  Assets held for sale   212  222  465,301  478,328  Property, plant and equipment  2(c) 266,211  268,107  Deposits and other long-term assets 6,507  7,722  Lease receivable 4,871  5,256  Intangible assets 47,096  45,163  Goodwill 43,689  43,871  Deferred tax assets 2(c) 4,164  4,219  Total assets 837,839  852,666  Liabilities Current liabilities Accounts payable and accrued liabilities 81,288  73,605  Income taxes payable 6,892  7,601  Deferred reven